Last reviewed · How we verify
NCT04576962
County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana
trial testing Immunization Information System Review in Human Papillomavirus Vaccination in 122,152 participants. Completed in 24 January 2022.
24 January 2022
Quick facts
| Lead sponsor | Indiana University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 122,152 |
| Start date | 9 February 2021 |
| Primary completion | 24 January 2022 |
| Estimated completion | 24 January 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Immunization Information System Review
Conditions studied
- Human Papillomavirus Vaccination — all drugs for Human Papillomavirus Vaccination →
Sponsor
Indiana University
Who can join
Adults 9 to 14, any sex, with Human Papillomavirus Vaccination. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective is to document geographic variability in HPV vaccine series completion across the state of Indiana and to identify factors associated with low versus high rates of completion. Objective a: To map HPV vaccine series completion rates across Indiana's 92 counties for children aged 14 years and younger. Hypothesis: The investigators expect wide variability in completion rates from county to county. Further, the investigators expect significantly less variability in county-level administration of vaccines required for middle-school entry (Tdap, MenACWY, and HepA vaccines). Objective b: To identify county-level characteristics associated with HPV vaccine series completion rates across Indiana's 92 counties. Hypothesis: The investigators expect factors reflective of pragmatic obstacles to be associated with lower completion rates: such as lower population density, fewer primary health care providers (HCP) per capita, longer commute to work, lower median household income, and lower rates of insurance coverage of children.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04576962
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Human Papillomavirus Vaccination
Currently open trials in the same condition.
- NCT06808776 — Stories to Prevent (StoP) HPV Cancers · NA · recruiting
- NCT06161831 — HPV Vaccine Reminders - SEARCH II Study · NA · active not recruiting
Other Indiana University trials
Trials by the same sponsor.
- NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
- NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
- NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
- NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
- NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04576962 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indiana University
- Last refreshed: 25 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04576962.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing